- 2024 Outlook🔍
- Healthcare execs expect M&A activity to rise again in 2024🔍
- Recent M&A Deals🔍
- Global M&A in 2024🔍
- M&A Regional Markets Overview🔍
- Global life and health insurance mergers and acquisitions 🔍
- Life Sciences 2024 Dealmaking Trends & Outlook🔍
- Life Sciences Dealmaking Poised To Rebound In 2024🔍
Hospital merger activity is projected to increase in 2024
2024 Outlook: Diagnostic Imaging Centers and Radiology Practices
The regulations could also contribute to consolidation and increased joint venture activity in these markets as hospitals and health systems ...
Healthcare execs expect M&A activity to rise again in 2024 -survey
LONDON, Nov 14 (Reuters) - Merger and acquisition (M&A) activity in the global healthcare sector should continue to rise next year, ...
Recent M&A Deals, Upcoming & Largest Deals (2024 Updated)
... projected increases in demand. 10. SAP acquisition of WalkMe. Projected Date: Q3 2024; Value: $1.5 billion; Industry: Tech. Software giant SAP ...
Global M&A in 2024: Five trends to watch - Clifford Chance
"We can expect M&A activity in the healthcare & life sciences sector to be affected by continuing and new supply chain issues in 2024. These issues are ...
2024: Healthcare Insiders Predict The Future - Forbes
Projections indicate a substantial 14 percent growth in the employment of community health ... healthcare merger and acquisition activity in 2024.
M&A Regional Markets Overview | BCG
M&A activity in India has been strong in 2024, bucking the trend in other Asia-Pacific markets. This robust performance marks a reversal of the ...
Global life and health insurance mergers and acquisitions (M&A)
Stability is often key to activity in insurance mergers and acquisitions—and 2023 was anything but stable. High inflation and interest rates ...
Life Sciences 2024 Dealmaking Trends & Outlook | Insights
In 2023, market activity generally bounced back to pre-pandemic levels, though still not close to the biotech market exuberance seen in 2021.
Life Sciences Dealmaking Poised To Rebound In 2024
Life sciences M&A deal activity declined from 2022 to 2023, with performance varying by subsector. Overall transaction volume declined by 22%, while deal values ...
mental health activities, an increase of $2.2 billion over. FY 2023 enacted ... increased workloads are projected to yield savings to. Medicare and ...
The potential for rapid consolidation of health systems - Deloitte
Inpatient hospital revenue forecasted based upon the National Health. Expenditure (NHE) projections from. CMS for 2019 to 2027 (which takes population trends ...
Teladoc Health Reports Fourth Quarter and Full Year 2023 Results
“As we look at 2024 and beyond, we are excited for the future. We remain focused on serving our clients globally, delivering world-class health ...
Key Trends in U.S. Benefits for 2024 and Beyond | Aon
Projected Healthcare Cost Increases in 2024 · Increasing employee cost sharing. More than one third of respondents said they are adjusting their ...
2024 Global Healthcare & Medical Industry Report
Over 60% of survey respondents expect deal volume to increase in 2024. Health systems will pursue partnerships to grow share (especially with ...
New AHA Report: Hospitals and Health Systems Continue to Face ...
These headwinds persist in 2024 and have been further exacerbated by the recent unprecedented Change Healthcare cyberattack, forcing many ...
Barriers and facilitators to successful hospital mergers
Kjekshus L and Hagen T (2007) Do hospital mergers increase hospital efficiency? ... Hospital performance (hospital activity, money staff). Quality (NHS ...
Health Cost and Affordability Policy Issues and Trends to Watch in ...
Health spending in the United States is projected to grow by 5% between 2023 and 2024, to a total of $4.9 trillion. Here are key health costs and affordability ...
2024 Outlook: Home Health, Hospice and Personal Care
2 Home healthcare expenditures had been increasing at a rate of approximately four to five percent per year from 2014 through 2019. In 2020, ...
Announcement of Calendar Year (CY) 2024 Medicare Advantage ...
The policies finalized for CY 2024 are projected to increase average payments to MA ... health agency, and outpatient hospital projections ...
Biopharma M&A outlook for 2024 - IQVIA
Biopharma M&A activity has witnessed a decisive rebound in 2023, with aggregate deal value up by 79% vs. 2022 to reach ~$152Bn for the full year, the highest ...